¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"insulin shock therapy"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • shock lung
    ¼îÅ©Æó, ¼îÅ©ÇãÆÄ
  • shock treatment
    Ãæ°ÝÄ¡·á
  • shock wave lithotripsy
    Ãæ°ÝÆÄ¼â¼®(¼ú)
  • vagogenic shock
    ¹ÌÁֽŰæ¼îÅ©
  • antibiotic therapy
    Ç×»ýÁ¦¿ä¹ý
  • acetylsalycylic acid antiplatelet therapy
    ¾Æ¼¼Æ¿»ì¸®½Ç»êÇ×Ç÷¼ÒÆÇ¿ä¹ý
  • acid therapy
    »ê¿ä¹ý
  • adjuvant therapy
    º¸Á¶¿ä¹ý
  • behavioral therapy
    Çൿ¿ä¹ý
  • biologic therapy
    »ý¹°ÇÐÀûÁ¦Á¦¿ä¹ý
  • client-centered therapy
    ³»´ãÀÚÁ߽ɿä¹ý, ÀÇ·ÚÀÎÁ߽ɿä¹ý
  • cognitive therapy
    ÀÎÁö¿ä¹ý
  • cold therapy
    ÇÑ·©¿ä¹ý, Àú¿Â¿ä¹ý
  • combined modality therapy
    º´¿ë¿ä¹ý
  • compression therapy
    ¾Ð¹Ú¿ä¹ý
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • septic shock
    ÆÐÇ÷¼îÅ©
  • serum shock
    Ç÷û¼îÅ©
  • shell shock
    Æ÷ź¼îÅ©, Æ÷ÅºÃæ°ÝÁõ
  • shock syndrome
    Ãæ°ÝÁõÈıº
  • shock treatment
    Ãæ°ÝÄ¡·á
  • spinal shock
    ô¼ö¼îÅ©
  • surgical shock
    ¼ö¼ú¼îÅ©
  • tourniquet shock
    ¾Ð¹Ú¶ì¼îÅ©
  • toxic shock
    µ¶¼º¼îÅ©
  • toxic shock syndrome
    µ¶¼ÒÃæ°ÝÁõÈıº
  • traumatic shock
    ¿Ü»ó¼îÅ©
  • vagogenic shock
    ¹ÌÁֽŰæÃæ°Ý
  • activity therapy
    Ȱµ¿¿ä¹ý
  • adaptive radiation therapy
    ÀûÀÀ¹æ»ç¼±Ä¡·á, ¼øÀÀ¹æ»ç¼±¿ä¹ý
  • adjuvant therapy
    º¸Á¶¿ä¹ý
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • adaptive radiation therapy
    ÀûÀÀ¹æ»ç¼±Ä¡, ¼øÀÀ¹æ»ç¼±Ä¡·á
  • adjuvant therapy
    º¸Á¶¿ä¹ý.
  • adjuvant therapy
    º¸Á¶¿ä¹ý, º¸Á¶Ä¡·á
  • androgen therapy
    ³²¼ºÈ£¸£¸ó ¿ä¹ý
  • antiandrogenic therapy
    Ç׳²¼ºÈ£¸£¸ó¿ä¹ý.
  • anticoagulant therapy
    Ç×ÀÀ°í¿ä¹ý.
  • antiestrogen therapy, for sexual dysfunction
    Ç׿¡½ºÆ®·Î°Õ ¿ä¹ý(¼º±â´ÉÀå¾ÖÀÇ)
  • antifungal therapy
    Ç×°õÆÎÀÌÄ¡·á
  • antimicrobial therapy
    Ç×±Õ¿ä¹ý(ù÷жèþÛö).
  • art therapy
    ¿¹¼ú¿ä¹ý
  • fractionated stereotactic radiation therapy
    ºÐÇÒÁ¤À§ ¹æ»ç¼±Ä¡·á
  • gold therapy
    ±Ý Ä¡·á
  • gonadotropin therapy
    ¼º¼±ÀÚ±ØÈ£¸£¸ó¿ä¹ý.
  • grenz-ray therapy
    ±×·£Â꼱ġ·á
  • health resort therapy
    ÀüÁö¿ä¹ý(ÊÙËíËÑ).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • non-suppressible insulin-like activity
    ºñ¾ïÁ¦Àν¶¸°¾ç Ȱ¼º
  • oral insulin substitute
    °æ±¸(Àû) ´ë¿ë(ÌèÏ¢îÜÓÛéÄ)Àν¶¸°, °æ±¸(Àû) Àν¶¸° ´ë¿ë¾à(¡­ÓÛéÄå·).
  • oral insulin substitute
    °æ±¸(Àû) ´ë¿ë(ÌèÏ¢(îÜ) ÓÛéÄ)Àν¶¸°, °æ±¸(Àû) Àν¶¸° ´ë¿ë¾à(¡­ÓÛéÄå·).
  • protamin insulin(e)
    ÇÁ·ÎŸ¹ÎÀν¶¸°.
  • protamin(e) insulin
    ÇÁ·ÎŸ¹ÎÀν¶¸°.
  • protamin(e) zinc insulin
    ÇÁ·ÎŸ¹Î¾Æ¿¬ Àν¶¸°.
  • protamin(e) zinc insulin
    ÇÁ·ÎŸ¹Î¾Æ¿¬ Àν¶¸°.
  • purified insulin
    ¼ø¼öÀν¶¸°.
  • short acting insulin
    ¼ÓÈ¿¼º Àν¶¸°.
  • suppressive insulin
    ¾ïÁ¦Çü(åäð¤úþ)Àν¶¸°.
  • ultralente insulin
    ÃÊÁö¿¬¼º Àν¶¸°.
  • zinc insulin crystals
    ¾Æ¿¬Àν¶¸°°áÁ¤(¡­Ì¿ïÜ).
  • anaphylactic shock
    ¾Æ³ªÇʶô½Ã¼º ¼ï, °ú¹Î¼º ¼ï.
  • anaphylactic shock
    ¾Æ³ªÇʶô½Ã½º¼º ¼ï, °ú¹Î¼º ¼ï.
  • bacterial shock
    ¼¼±Õ¼º ¼ï
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
AMI Acute Myocardial Infarction
  - Complications(Cx)
    1. Early ...
DSS   1) Double Simultaneous Stimulation
  2) Dengue Shock Syndrome
ECG Electro-Cardio-Graphy(-Gram); ½ÉÀüµµ
   = EKG
  1. Conducting System Structu...
EST(?) Electric(Electro-) Shock Theraphy; Àü±â Ãæ°ÝÄ¡·á
  = ECT
ESWL Extracorporeal Shock-Wave Lithotripsy
  - Ix for Gall Stone
    ...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
HSP-70 Heat shock protein
hsp90 Heat shock protein
HSP 47 Heat shock protein 47
HSP60 Heat shock protein 60
HSP-65 Heat shock protein 65
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • educational therapy
    ÈÆ·Ã ¿ä¹ý
  • electrical stimulation therapy
    Àü±â ÀÚ±Ø ¿ä¹ý
  • electroconvulsive therapy
    Àü±â °æ·Ã ¹æ¹ý, Àü±â °æ·Ã ¿ä¹ý, Àü±â °æ·Ã Ä¡·á
    1. Àü±â ¼ïÀÇ ¹æ¹ý¿¡ ÀÇÇØ¼­ °æ·ÃÀ» À¯¹ßÇÏ´Â Ä¡·á¹ý. 2. Àü·ù¸¦ ³ú¿¡ ÅëÇØ¼­ °æ·ÃÀ» À¯µµÇÏ´Â °Í. ÁÖ·Î Á¤µ¿ Àå¾ÖÀÇ Ä¡·á¿¡ »ç¿ëµÈ´Ù. Çö´ëÀÇ ½ÇÁö ÀÇ·á¿¡¼­´Â ±ÙÀ°ÀÌ¿ÏÁ¦ÀÇ Àû¿ë¿¡ ÀÇÇØ¼­ °æ·Ã Áõ»óÀ» ÃÖ¼ÒÇÑÀ¸·Î °æ°¨½ÃŲ´Ù.
  • electrogalvanic stimulation therapy
    °¥¹Ù´Ð Àü±â ÀÚ±Ø Ä¡·á
  • electron beam therapy
    ÀüÀÚ¼± Ä¡·á
  • endodontic therapy
    ±Ù°ü Ä¡·á
  • exercise therapy
    ¿îµ¿ Ä¡·á
  • extension therapy
    °ßÀÎ ¿ä¹ý
    Áö¼ÓÀûÀ¸·Î °ßÀηÂÀ» ÀÛ¿ë½ÃÄÑ ±ÙÀ°À» Ä¡·áÇÏ´Â ¹ý. ±ÙÀ°Àº Ÿ¹ÚÀ̳ª ¿Ü»ó ¶§ ÀåÃà ¹æÇâÀ¸·Î ´ÜÃàµÇ´Â ÀÏÀÌ ¸¹¾Æ¼­, ¿°ÁÂ, Á»ó, ±×¸®°í ¾î¶² Á¾·ùÀÇ °ñÀý¿¡¼­´Â ÀåÃà ¹æÇâÀ¸·Î Áö¼ÓÀûÀ¸·Î °ßÀÎÇÒ Çʿ䰡 ÀÖ´Ù. °£´ÜÇÑ °ßÀοä¹ýÀ¸·Î´Â ¹Ýâ°íÀÇ ÀÀ¿ëÀÌ ÀÖÀ¸¸ç, ±³Åë»ç°í ¶§ ¸¹ÀÌ ÀϾ´Â °æÃß ¿°Á¿¡´Â ¾Æ·¡ÅÎÀ» °íÁ¤½Ã۰í üÁßÀ» ÀÌ¿ëÇÏ´Â °ßÀαⰡ °í¾ÈµÇ¾î ÀÖ´Ù. ±× ¹Û¿¡ °­¼±À» Ȱ¿ëÇÏ¿© »À¿¡ Á÷Á¢ °ßÀηÂÀ» ¹ÌÄ¡´Â ¹æ¹ýµµ ÀÖ´Ù.
  • fluid therapy
    ¼ö¾× ¿ä¹ý
  • fluoride therapy
    ºÒ¼Ò Ä¡·á, ºÒ¼Ò óġ
  • heat and cold therapy
    ³Ã¿Â ¿ä¹ý
    Â÷°¡¿î ÆÐµå¿Í ¶ß°Å¿î ÆÐµå¸¦ ¹ø°¥¾Æ°¡¸ç º´¼Ò¿¡ ´ë°í Ç÷¾× ¼øÈ¯À» ÃËÁø½Ã۰í ÅëÁõÀ» ¿ÏÈ­½ÃŰ´Â ¹æ¹ý.
  • indirect pulp therapy
    °£Á¢ Ä¡¼ö Ä¡·á
  • infrared laser therapy
    Àû¿Ü¼± ·¹ÀÌÀú ¿ä¹ý
    µ¿ÀǾî=cold laser thera
  • initial therapy
    Ãʱâ Ä¡·á
  • irreversible occlusal therapy
    ºñ°¡¿ªÀûÀÎ ±³ÇÕ Ä¡·á, ºñ°¡¿ªÀû ±³ÇÕ Ä¡·á
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
insulin-stimulating peptide <chemical> 71-amino acid containing peptide; corresponds to residues 115-143 and 144-184 of bovine serum albumin with the exception of a tyrosine insertion between residues 155 and 156; consists of two chains with mw 5000 and 3400 for each chain
Synonym: h-isp, insulin-stimulating protein
(05 Dec 1998)
insulin unit The activity contained in 1/22 mg of the international standard of zinc-insulin crystals.
(05 Mar 2000)
insulin zinc suspension A sterile buffered suspension with zinc chloride, containing 40 or 80 units per ml; the solid phase of the suspension consists of a mixture of 7 parts of crystalline insulin and 3 parts of amorphous insulin.
Synonym: lente insulin.
(05 Mar 2000)
extended insulin zinc suspension A long-acting insulin suspension, obtained from beef, with an approximate time of onset of 7 hours and a duration of action of 36 hours.
Synonym: crystalline insulin zinc suspension.
(05 Mar 2000)
ultralente insulin A form of zinc precipitated insulin in suspension in which the particle size is large, and thus release into the bloodstream after subcutaneous injection is slow; it can be mixed with other insulins having different particle sizes to achieve different durations of activity. Can be derived from porcine, bovine, or genetically engineered human type.
(05 Mar 2000)
lente insulin A sterile buffered suspension with zinc chloride, containing 40 or 80 units per ml; the solid phase of the suspension consists of a mixture of 7 parts of crystalline insulin and 3 parts of amorphous insulin.
Synonym: lente insulin.
(05 Mar 2000)
anaesthetic shock Shock produced by the administration of anaesthetic drug(s), usually in relative overdosage.
(05 Mar 2000)
anaphylactic shock <immunology> A serious, often life-threatening allergic reaction that is characterised by low blood pressure, shock (poor tissue perfusion) and difficulty breathing.
(27 Sep 1997)
anaphylactoid shock A reaction that is similar to anaphylactic shock, but which does not require the incubation period characteristic of induced sensitivity (anaphylaxis); it is unrelated to antigen-antibody reactions.
Synonym: anaphylactoid crisis, pseudoanaphylactic shock.
(05 Mar 2000)
break shock The shock produced by breaking a constant current passing through the body.
(05 Mar 2000)
cardiac shock A form of shock (inadequate delivery of oxygen to the tissues) that occurs secondary to the weakened pumping function of the heart. This condition may be precipitated by myocardial infarction or cardiomyopathy.
Treatment includes fluid restriction, diuretics, vasopressors (dopamine) to support the blood pressure and the use of intravenous medications (dobutamine) which stimulate the heart to contract more forcefully.
(27 Sep 1997)
cardiogenic shock A form of shock (inadequate delivery of oxygen to the tissues) that occurs secondary to the weakened pumping function of the heart. This condition may be precipitated by myocardial infarction or cardiomyopathy.
Treatment includes fluid restriction, diuretics, vasopressors (dopamine) to support the blood pressure and the use of intravenous medications (dobutamine) which stimulate the heart to contract more forcefully.
(27 Sep 1997)
cardiopulmonary obstructive shock <cardiology> This term describes a number of conditions that involve a severe disturbance of the cardiopulmonary circuit resulting in shock (inadequate delivery of oxygen to the tissues).
Examples include: pulmonary embolism, pericardial tamponade, pneumothorax and constrictive pericarditis.
(27 Sep 1997)
vasogenic shock Shock resulting from depressed activity of the higher vasomotor centres in the brain stem and the medulla, producing vasodilation without loss of fluid so that the container is disproportionately large. In oligaemic shock, blood volume is reduced; in both, return of venous blood is inadequate.
(05 Mar 2000)
reversible shock Shock that will respond to treatment and from which recovery is possible.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 5
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 5
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 5
ÅëÇÕ°Ë»ö ¿Ï·á